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The composition of human skin acts as a natural habitat for various bacterial species
that function in a commensal and symbiotic fashion. In a healthy individual, bacterial flora
serves to protect the host. Under certain conditions such as minor trauma, impaired host
immunity, or environmental factors, the risk of developing skin infections is increased.
Although a large majority of bacterial associated skin infections are common, a portion
can potentially manifest into clinically significant morbidity. For example, Gram-positive
species that typically reside on the skin such as Staphylococcus and Streptococcus
can cause numerous epidermal (impetigo, ecthyma) and dermal (cellulitis, necrotizing
fasciitis, erysipelas) skin infections. Moreover, the increasing incidence of bacterial
antibiotic resistance represents a serious challenge to modern medicine and threatens
the health care system. Therefore, it is critical to develop tools and strategies that
can allow us to better elucidate the nature and mechanism of bacterial virulence.
To this end, mass spectrometry (MS)-based proteomics has been revolutionizing
biomedical research, and has positively impacted the microbiology field. Advances in MS
technologies have paved the way for numerous bacterial proteomes and their respective
post translational modifications (PTMs) to be accurately identified and quantified in a high
throughput and robust fashion. This technological platform offers critical information with
regards to signal transduction, adherence, and microbial–host interactions associated
with bacterial pathogenesis. This mini-review serves to highlight the current progress
proteomics has contributed toward the understanding of bacteria that are associated
with skin related diseases, infections, and antibiotic resistance.
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INTRODUCTION
Skin has a primary role to act as a physical barrier in order to protect the body from temperature
variations, microorganisms, or toxic substrates. While in utero skin is sterile, after birth it
becomes rapidly colonized with numerous microorganisms which aids toward protecting the
body (Capone et al., 2011). Bacterially derived dermatologic conditions can range from relatively
benign conditions (assuming non-immunocompromised patients) such as cellulitis, erysipelas,
folliculitis, or impetigo to serious clinical morbidity, such as necrotizing fasciitis (Stulberg et al.,
2002). Underlying medical conditions such as diabetes mellitus or AIDS are examples where
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commensal bacteria can invade the skin resulting in infections
that can manifest from mild to the life threatening (Swartz, 2004).
In recent years there have been growing concerns with
respect to the challenges faced in the emergent inability to
provide effective therapeutic interventions for patients with
pathologies of bacterial etiology, due to increasing rates of
antibiotic resistance. Considering the ease of transmission with
respect to resistance genes amongst mucosal and epidermal flora,
special consideration should be given to dermatologic related
bacterial conditions (Espersen, 1998).
Mass spectrometry (MS)-based proteomics has the capability
to study proteins and their interactions in order to better
understand dysregulations in infection disorders (List et al.,
2008), reveal antibiotic resistance mechanisms (Lee et al., 2015)
and significant new targets for future drug discovery. Current
MS-based proteomics technologies have advanced to the point
where they are amenable to any biological system. With regards
to bacterial organisms, they are particularly attractive models
to apply proteomics based approaches due to their smaller
proteomes and modifications compared to eukaryotes allowing
for comprehensive proteome coverage (Stekhoven et al., 2014).
SKIN MICROBIOME
The skin is host to many different bacterial species,
fungi, viruses and mites. Most of the bacteria fall into
four phyla: Actinobacteria, Firmicutes, Bacteroidetes, and
Proteobacteria from which Propionibacterium, Corynebacterium,
Staphylococcus, Micrococcus, Streptococcus, and Brevibacterium
are highly abundant (van Rensburg et al., 2015) Gram-positive
bacteria, since Gram-negative members typically cannot cope
with the relatively dry environment of healthy human skin (Del
Rosso and Leyden, 2007). In certain physiological conditions
where the skin becomes moist, some Gram-negative bacteria
can colonize such as Acinetobacter sp. (Del Rosso and Leyden,
2007). The diverse community of the skin, known as the skin
microbiome, is defined by host physiology, host genotype,
immune system, environment, and lifestyle (Grice and Segre,
2011). However, most of these microorganisms are harmless
and many bacterial species act in a commensal fashion by
which each species benefits through the exchange of nutrients
as well as protect the host from pathogens without negatively
affecting each other (Mankowska-Wierzbicka et al., 2015).
Knowledge toward the bacterial microbiome is mainly derived
from the conventional culture-based approaches, although in
recent years DNA sequencing technologies combined with
bioinformatic analysis and metagenomics approaches have
allowed comprehensive examination of microbial communities
(Kuczynski et al., 2012), yet uncertainties remain as to what
defines a “normal” microbiome (Backhed et al., 2012).
The underlying contribution of the microbiome in the
clinical picture of skin disorders is clear from the perspective
of antibacterial treatment, however, the molecular dynamics
between the microbiome and host remains largely unknown.
Disturbances in homeostasis between microbiome and host can
manifest into skin disorders such as atopic dermatitis (AD) or
psoriasis (Kuo et al., 2013). Both disorders are connected with
dysregulation of the skin immune response. However, while
AD lesions are characterized by low level, psoriatic lesions are
characterized by high level of antimicrobial peptide production
(Nomura et al., 2003). Additionally, AD lesions are regularly
infected with microbial pathogens.
The bacterial genus of Staphylococcus sp. is composed of
approximately 40 different species both commensal (unable
to produce virulence factor coagulase) and pathogenic, and
play an important role in skin health and pathology (Del
Rosso and Leyden, 2007). For example, Staphylococcus aureus
is a medically relevant bacterial pathogen that is associated
with the increasing rate of antibiotic resistance mechanisms
as well as systemic and cutaneous infections (Becker et al.,
2007), including AD (Hanifin and Rogge, 1977). However, it
was previously thought that S. aureus causes AD alone, a
recent study showed that the skin microbiome composition
has a temporal change and it depends on disease flares and
treatment. In the active state of the disease, the abundance of
S. aureus and skin commensal S. epidermidis was increased,
while Streptococcus, Propionibacterium, and Corynebacterium
were increased following therapy (Kong et al., 2012). Increased
abundance of S. epidermidis could reflect a microbial response
to overgrowth of S. aureus, since it can selectively inhibit
S. aureus growth (Iwase et al., 2010; Zeeuwen et al., 2013).
Moreover, a recent study identified the presence of a distinct
microbiome capable of direct communication with the host at
the sub-epidermal compartments of the skin, an area previously
thought to be sterile (Nakatsuji et al., 2013). While these types
of studies employing different techniques have characterized the
bacterial species that make up the skin microbiome, proteomics
is required in order to identify proteins and their respective
pathways involved during these interactions, which could directly
contribute to the better understanding of the complex interplay
between microbiome and host.
SHOTGUN MS-BASED PROTEOMICS
Due to the progress made toward state of the art next generation
sequencing methodologies applied to generate fully annotated
genomes, the number of fully sequenced microbial genomes
has increased dramatically (Ribeiro et al., 2012). This has
enabled state of the art MS-based proteomics technologies to
rapidly advance in order to study microbial models and their
communities in a robust and systematic fashion.
Two-dimensional polyacrylamide gel electrophoresis (2D-
PAGE), followed by MS analysis has served as the main
proteomics method of choice in the past and has been utilized
in many skin associated bacterial pathogen studies (Kohler et al.,
2005; Becher et al., 2009; Francois et al., 2014). In this technique,
proteins are separated according to their molecular weight and
isoelectric point migrating and accumulating as protein spots on
the gel matrix. Although this approach can resolve multiples of
thousands of proteins, it does carry some disadvantages especially
with respect toward the identification of low abundant proteins,
proteins with extremely high and low molecular weights, and
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is rather impractical with respect to large scale site specific
analysis of post translational modifications (PTMs) such as
phosphorylation.
The inherent limitations associated with 2D-PAGE MS lead
to the development of gel-free MS-based approaches better
known as “shotgun” proteomics. Advances made in shotgun
based proteomics approaches is largely due to technological
improvements made in high performance mass spectrometers.
Since most biological samples consist of very complex peptide
mixtures, mass spectrometers must be capable of ensuring a
deep analytical coverage while maintaining a high level of
robustness, sensitivity, and measurement accuracy (Mann and
Kelleher, 2008). Newer generations of hybrid mass spectrometers
such as but not limited to the LTQ-Orbitrap (Hu et al.,
2005), LTQ Orbitrap Velos (Olsen et al., 2009), Q-Exactive
HF (Scheltema et al., 2014), and Orbitrap Fusion (Erickson
et al., 2015) can achieve precise mass accuracy at very high
acquisition speeds, and resolution which allows for a complete
sampling of complex peptide extracts providing comprehensive
proteome coverage. Combined with high performance liquid
chromatography (HPLC) technologies, these LC-MS workflows
also referred to as gel-free shotgun proteomics allow for the
quantification and identification of entire proteomes as well as
their protein modifications across different biological samples.
An overview of a typical shotgun MS-based experimental
workflow is illustrated in Figure 1.
For example, a similar approach as described above was
applied to the bacterium Propionibacterium acnes (Bek-Thomsen
et al., 2014). P. acnes is known to be associated with the
inflammatory condition of the sebaceous human follicles known
as acne vulgaris (Williams et al., 2012). The authors utilized
proteomics in order to identify both human and P. acnes proteins
using sebaceous follicular casts. To this end, many proteins
involved in wound healing, inflammation, and tissue formation
were identified. The most abundant P. acnes proteins were
CAMP factors, and surface exposed dermatan sulfate adhesins.
FIGURE 1 | Example of shotgun proteomics workflow. This workflow provides a blueprint that can decode protein dynamics from complex crude protein
extracts toward elucidation of numerous novel biological functions. (A) Cells are grown in culture or other growth models, and lysed using various procedures. (B)
Protein extracts are digested for example by trypsin to generate peptides. (C) Peptides are fractionated in order to decrease peptide complexity which increase both
identification and quantification rates upon MS analysis. (D) If PTM analysis is required, various enrichment strategies can be performed such as titanium
chromatography in the case of phosphopeptide enrichment. (E) Resulting peptide extracts are separated on nanoflow HPLC and measured on a high resolution
mass spectrometer (e.g., Thermo Scientific Q Exactive HF). (F) Relative peptide quantitation (full-scan MS). (G) Peptide identification through sequencing and
detection to acquire MS/MS spectra. (H) Data processing utilizing numerous bioinformatic approaches.
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This study is the first of its kind in terms of analyzing the
proteomes of both humans and bacteria on sebaceous follicular
casts and demonstrates the importance of employing shotgun
based proteomics workflows (Bek-Thomsen et al., 2014).
A recent study employed a combinatorial approach
utilizing 16SrRNA sequencing with ultra-performance liquid
chromatography/quadrupole time of flight (UPLC-TOF) MS
toward the generation of a 3-dimensional topographical map of
microbes and their molecules of origin (peptides, metabolites)
distributed on the surface of the human skin (Bouslimani et al.,
2015). This information was utilized to identify microbial species
present and correlated with the chemical environment of the
skin and serves as a powerful approach toward elucidating how
the microbiome interacts and subsequently modifies different
areas of the human skin in a species specific fashion.
SHOTGUN MS-BASED QUANTITATIVE
PROTEOMICS
The complete identification of a proteome and its respective
PTMs provides a better understanding toward biological
function and regulation. However, it is equally important to
quantify dynamics of proteins relative to each other under
different biological conditions, disease states, and perturbations.
This information can be obtained through the use of quantitative
proteomics of which numerous approaches have been developed
that are compatible with shotgun MS-based proteomics
strategies.
One common approach is to introduce a stable non-
radioactive isotope label either chemically or metabolically on
the peptide or protein level. Through this technique, the relative
intensities of peptides are measured, via MS thus identifying and
quantifying regulated proteins from different samples through
the obtained mass spectra. Examples of such techniques include
but they are not limited to Stable Isotope Labeling by Amino
acids in Cell culture (SILAC; Ong et al., 2002) or 15N labeling
(Hempel et al., 2010; Soufi et al., 2015), both of which have
been successfully implemented in a variety of bacteria (Soufi
et al., 2010, 2015; Hempel et al., 2011; Soares et al., 2013;
Misra et al., 2014; Soufi and Macek, 2014; Boysen et al., 2015).
Furthermore, an innovative MS-based technique known as cell
type-specific labeling using amino acid precursors (CTAP) has
the ability to continuously label the proteome of individual cell
types actively growing in a co-culture environment, allowing for
the elucidation of the “cell-of-origin” of proteins in multicellular
environments (Gauthier et al., 2013). Although this method
was demonstrated in eukaryotic models, the application toward
bacteria especially those in multispecies environments, such as
human microbiomes, biofilms, etc. could significantly contribute
toward the better understanding of the dynamics between
different bacterial species inhabiting the same environment.
Although metabolic labeling approaches such as SILAC
are considered by many to be the most accurate method
toward global protein quantitation (Ong et al., 2002), they
may be difficult to implement due to technical challenges with
incorporation of the chemical or metabolic labeling approach,
or challenges posed in complex biological models such as those
involving the skin. Therefore, due to rapid advances made in LC-
MS, label free quantitation (LFQ) approaches are now possible
and routinely performed (Neilson et al., 2011). In this approach,
different peptide samples are measured via MS and compared
either by the total number of sequenced (MS/MS) spectra or the
total extracted ion currents under controlled conditions.
The LFQ methodology was successfully applied to study the
role of S. aureus in patients with ectodermal dysplasia and AD
(Burian et al., 2015). Patients suffering from AD are highly
correlated with the presence of opportunistic S. aureus infections
due to having a reduced immune response, and have been
shown to contain a lower amount of peptides originating from
the natural antimicrobial dermcidin found in sweat leading to
decreased levels of antimicrobial activity (Schittek, 2011). The
authors proved through proteomics analysis of the secretome of
diseased vs. healthy patients that a similar mechanism of reduced
sweat derived dermcidin also exists in patients with ectodermal
dysplasia, making these individuals highly prone to acquiring
S. aureus infections (Burian et al., 2015).
Quantitative proteomics techniques can be utilized to estimate
the absolute molar amount or concentration of a particular
protein per cell. This information is highly relevant especially
within the clinical context (Rodriguez-Suarez and Whetton,
2013). Many variants of this technique exist and all involve
spiking in a known concentration of an internal protein standard
into the sample, followed by MS analysis, and comparing
resulting sample peptide measurements to the internal standard.
Techniques include FLEXIQuant (Singh et al., 2009), absolute
quantification using protein epitope signature tags (PrEST; Zeiler
et al., 2012), intensity based absolute quantification (iBAQ;
Schwanhausser et al., 2011), and absolute quantification (AQUA;
Gerber et al., 2003). These methods can be applied to bacteria and
serve as an important tool toward understanding the underlying
mechanisms during bacterial virulence and antibiotic resistance.
POST TRANSLATIONAL
MODIFICATIONS (PTMS)
Various PTMs on bacterial proteins such as phosphorylation,
acetylation, methylation, and deamidation serve as an efficient
means of controlling signal transduction, virulence and
regulatory processes. PTMs represent a significant process in the
life cycle of bacteria and can modulate key virulence factors and
are attractive targets for novel therapies.
Detecting these PTMs in bacteria poses a technical challenge
due to the fact that they are difficult to discover as these
modifications typically exist at low levels of abundance. To
circumvent this issue, specific enrichment strategies targeting
certain PTMs can be utilized in order to decrease peptide
complexity thereby increasing the likeliness of detection
and subsequent characterization. For example, immunoaffinity
enrichment is typically employed to select for lysine acetylated
peptides (Rardin et al., 2013). Moreover, similar enrichment
strategies are employed to capture phosphorylation events on
serine, threonine, and tyrosine (S/T/Y) amino acid residues.
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These PTMs were once thought to exist solely in eukaryotes,
however, MS-based proteomics combined with phosphopeptide
enrichment strategies such as titanium dioxide chromatography
(TiO2; Pinkse et al., 2004), immunoprecipitation (Rush et al.,
2005) or immobilized metal ion affinity chromatography
(IMAC; Villen and Gygi, 2008) have now established S/T/Y
phosphorylation as a frequent and important PTM among
different bacterial species (Macek et al., 2007, 2008; Soufi et al.,
2008; Lin et al., 2009; Sun et al., 2010; Manteca et al., 2011; Misra
et al., 2011; Cousin et al., 2013).
A recent shotgun based high resolution LC-MS/MS approach
involving the enrichment of surface proteins using “trypsin
shaving” was applied to the opportunistic pathogen S. aureus
toward the identification of hydroxymethylation on aspargine
and glutamine amino acid residues in an attempt to identify the
presence and potential regulatory importance of this PTM on
surface proteins which are known to assist in the colonization
and invasion of the host cell (Waridel et al., 2012). The authors
reported a total of 15 proteins (mostly surface proteins) that
contained hydroxymethylation modifications and could play a
role in virulence factor modulation.
Pseudomonas aeruginosa, an opportunistic bacterial pathogen,
is associated with immunocompromised patients and nosocomial
infections. P. aeruginosa infections can enter the body through
the skin, and can be life threatening due to their ability to
develop antibiotic resistance (Ouidir et al., 2015). A study
involving P. aeruginosa, employed an effective combinatorial
method of immunoaffinity assays, complex peptide fractionation,
and shotgun proteomics toward the identification and
characterization of lysine acetylation, a reversible PTM that
has recently been implicated as an important regulatory
mechanism in many bacteria (Yu et al., 2008; Kim et al.,
2013; Zhang et al., 2013; Liao et al., 2014). This approach
lead to the identification of 320 acetylated proteins in a wide
variety of functional classes. The study also identified novel
lysine acetylation events in virulence factors known to assist
in host immune response evasion such as chitin binding
protein, serine protease, exotoxin A, and hemolysin which
potentially implies that lysine acetylation events in P. aeruginosa
plays a role in mechanisms involving virulence (Ouidir et al.,
2015).
Cysteine phosphorylation in S. aureus was shown to assist in
the regulation of bacterial virulence and vancomycin resistance
(Sun et al., 2012). Utilizing high resolution MS, the authors
elucidated in a site specific fashion, that cysteine phosphorylation
events occurred in various proteins many of which are global
regulators that control important biological processes (Sun
et al., 2012). Moreover, the eukaryotic-like Ser/Thr kinase and
phosphatase pair Stk1/Stp1 was found to regulate cysteine
phosphorylation in many Gram-positive bacteria providing an
important piece of information toward the underlying regulatory
mechanism of these events (Sun et al., 2012).
CONCLUSION AND FUTURE OUTLOOK
A wide range of dermatological microbial associated diseases
presents current and future challenges to health care providers.
While in the last decade metagenomics data provided a higher
level of understanding of the microbial skin environment,
understanding signal transduction, virulence, regulatory
processes, and dynamics between different bacterial species is
essential in order to improve the overall standards and quality
of patient care and treatment. MS-based proteomics has the
capability to provide this knowledge. To this end, a ground-
breaking endeavor with proteomics at the forefront is required
in order to elucidate the specific mechanisms involved in skin
infections, bacterial resistance as well as the complex microbiome
and host relationship.
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